Oracea (Doxycycline)

Oracea, a doxycycline‑based tetracycline, acts on the inflammatory pathway of rosacea.

• Rosacea (papulopustular lesions): reduces the number and severity of papules and pustules on the face.
• Rosacea (maintenance therapy): helps maintain clear skin after an initial treatment course.
• Rosacea (adult patients): provides a targeted oral option for adults with persistent inflammatory lesions.

• Doxycycline binds to the 30S ribosomal subunit of susceptible bacteria, inhibiting protein synthesis and exerting anti‑inflammatory effects by suppressing matrix metalloproteinases and cytokine production, which together reduce the inflammatory lesions characteristic of rosacea.

Common Side Effects

• Nausea: mild stomach upset may occur.
• Diarrhea: loose stools are reported in some patients.
• Photosensitivity: increased skin sensitivity to sunlight.
• Esophageal irritation: discomfort when the capsule is not taken with enough water.
• Vaginal candidiasis: occasional yeast infection.

Serious or Rare Side Effects

• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Hepatotoxicity: signs of liver injury such as jaundice.
• Pseudotumor cerebri: persistent headache and visual changes.
• Blood dyscrasias: unusual bruising or bleeding.
• Intracranial hypertension: severe headache with visual disturbances.

Before starting Oracea, consider the following precautions:

• Pregnancy: avoid use unless clearly needed; discuss risks with a healthcare professional.
• Breastfeeding: consult a physician as doxycycline may pass into breast milk.
• Liver disease: dose adjustment may be required in hepatic impairment.
• Renal impairment: monitor kidney function, especially in severe cases.
• Concomitant photosensitizing agents: limit sun exposure and use protective clothing.
• Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct light.

Oracea can interact with several medicines; monitor the following:

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of bleeding.
• Oral retinoids (e.g., isotretinoin): heightened intracranial hypertension risk.
• Vitamin/mineral supplements containing iron, calcium, magnesium, or aluminum: markedly reduce doxycycline absorption.

Moderate Interactions (Monitor Closely)

• Antiepileptics (e.g., phenytoin): may lower doxycycline levels.
• Oral contraceptives: reduced efficacy, consider backup contraception.
• Barbiturates and rifampin: may increase hepatic metabolism of doxycycline.